Who
Elizabeth G. Nabel
Director
Company insider
Files Form 4 as: Director, Lyell Immunopharma; Director, Moderna; Director, Medtronic plc; Director, Accolade.
In numbers
- Trades disclosed
- 107
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $10.5M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 27 Apr 2015
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | LYEL Lyell Immunopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,250 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | LYEL Lyell Immunopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,250 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,371 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,371 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —16,233 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,233 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,233 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —16,233 | filing |
| 28 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $17K207 at $81.90 | filing |
| 28 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $17K207 at $81.90 | filing |
| 27 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | —2,111 at $0.00 | filing |
| 27 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | —2,111 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | LYEL Lyell Immunopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 30 Apr 2025filed 1 May 2025 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —979 at $0.00 | filing |
| 30 Apr 2025filed 1 May 2025 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,233 at $0.00 | filing |
| 30 Apr 2025filed 1 May 2025 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —979 | filing |
| 29 Apr 2025filed 30 Apr 2025 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code F | $18K216 at $84.60 | filing |
| 28 Apr 2025filed 30 Apr 2025 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | $175K2,083 at $84.04 | filing |
| 8 Apr 2025filed 8 Apr 2025 | Accoladeoption or derivative | SEC FORM 4 Code D | —35,021 | filing |
| 8 Apr 2025filed 8 Apr 2025 | Accoladeoption or derivative | SEC FORM 4 Code D | —12,489 | filing |
News
Moderna (NASDAQ:MRNA) Shares Up 1.2% – Here's WhyMRNA · dailypolitical.com · 13 Oct 2026Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?MRNA · insidermonkey.com · 9 Oct 2026
0 headlines in the last 90 days name Elizabeth G. Nabel; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.